Ask AI
ProCE Banner Activity

CE

Best Practices for Managing Long-term Toxicities From CAR T-Cell Therapy: Educational Insights and Resources for Oncology Nurses in the Community

Video

In this certified on-demand webcast, an expert discusses practical strategies for oncology nurses to recognize and manage long-term toxicities associated with CAR T-cell therapy and provides guidance on patient eligibility, bridging therapy coordination, inpatient vs outpatient monitoring, and caregiver engagement.

Nurse Practitioners/Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit 

Released: October 10, 2025

Expiration: April 09, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Bristol Myers Squibb and Johnson & Johnson.

Bristol Myers Squibb

Johnson & Johnson

Target Audience

This activity has been designed to meet the educational needs of community oncology nurses, nurse practitioners, and other healthcare professionals who care for patients treated with CAR T-cell therapies.

Program Learning Goal

The goal of this activity is to improve the knowledge, confidence, and competence of community oncology nurses, nurse practitioners, and other healthcare professionals in educating and caring for patients treated with CAR T-cell therapies.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patients at increased risk for long-term toxicities related to CAR T-cell therapy

  • Counsel patients and caregivers on the onset, symptoms, and clinical manifestations of short-term vs long-term toxicities related to CAR T-cell therapy

  • Implement strategies to monitor for and manage long-term toxicities in patients treated with CAR T-cell therapy based on the latest guidelines, expert recommendations, and evidence

  • Develop plans for transitioning care from the CAR T-cell treating center to community practice that optimize the patient’s long-term safety and quality of life

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO: consultant/advisor/speaker: GlaxoSmithKline, Janssen, Sanofi.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 10, 2025, through April 09, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.

  2. Read the target audience, learning objectives, and faculty disclosures.

  3. View and study the content in its entirety.

  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour, including 1 hour of pharmacotherapy credit.

ILNA Recertification Points

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas:

  • Care Continuum (OCN, CBCN, CPHON, AOCNP) - 1.0*
  • Care of the Pediatric Hematology and Oncology Patient (CPHON) - 1.0*
  • Early Post-Transplant Management and Education (BMTCN) - 1.0*
  • Foundations of Transplant (BMTCN) - 1.0*
  • Health Maintenance (CPHON) - 1.0*
  • Late Post-Transplant Management and Education (BMTCN) - 1.0*
  • Oncologic Emergencies (OCN, CPHON, AOCNP) - 1.0*
  • Oncology Nursing Practice (OCN) - 1.0*
  • Pediatric Hematology and Oncology Nursing Practice (CPHON) - 1.0*
  • Psychosocial Dimensions of Care (AOCNP, CPHON, OCN, CBCN) - 1.0*
  • Quality of Life (BMTCN) - 1.0*
  • Symptom Management, Palliative Care, Supportive Care (OCN, CPHON, AOCNP) - 1.0*
  • Treatment (OCN, CBCN, AOCNP, CPHON) - 1.0*

Total Points: 1.0*

*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum number of points that can be claimed in each subject area. The total amount of ILNA points claimed may not exceed the total amount of nursing continuing professional development (NCPD) awarded from this course.